The store will not work correctly when cookies are disabled.
N-(1-Methyl-1H-pyrazol-3-yl)-4-phenoxybutanamide
ID: ALA4553355
PubChem CID: 31845722
Max Phase: Preclinical
Molecular Formula: C14H17N3O2
Molecular Weight: 259.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1ccc(NC(=O)CCCOc2ccccc2)n1
Standard InChI: InChI=1S/C14H17N3O2/c1-17-10-9-13(16-17)15-14(18)8-5-11-19-12-6-3-2-4-7-12/h2-4,6-7,9-10H,5,8,11H2,1H3,(H,15,16,18)
Standard InChI Key: JVTPSPSGEKTOST-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
9.1940 -28.1807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1929 -29.0002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9009 -29.4092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6106 -28.9997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6078 -28.1771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8992 -27.7718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4862 -27.7723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7786 -28.1810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0708 -27.7726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3632 -28.1814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6554 -27.7729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9478 -28.1817 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6552 -26.9557 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2400 -27.7733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1533 -26.9622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3539 -26.7925 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9454 -27.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4925 -28.1074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0213 -26.0460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 14 1 0
16 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 259.31 | Molecular Weight (Monoisotopic): 259.1321 | AlogP: 2.22 | #Rotatable Bonds: 6 |
Polar Surface Area: 56.15 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.37 | CX Basic pKa: 1.20 | CX LogP: 2.28 | CX LogD: 2.28 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.81 | Np Likeness Score: -2.00 |
References
1. Nguyen W, Jacobson J, Jarman KE, Jousset Sabroux H, Harty L, McMahon J, Lewin SR, Purcell DF, Sleebs BE.. (2019) Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models., 62 (10): [PMID:30973727] [10.1021/acs.jmedchem.9b00462] |